EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical and Genetic Characteristics of Congenital Hyperinsulinism in Norway: A Nationwide Cohort Study

Christoffer Drabløs Velde iD, Janne Molnes, Siren Berland, Pål Rasmus Njølstad iD, Anders Molven iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae459 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Christoffer Drabløs Velde und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway. Hauptthemen laut MEDLINE: Congenital Hyperinsulinism, Sulfonylurea Receptors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bergen, Western Norway Regional Health Authority, Research Council of Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Congenital hyperinsulinism (CHI) is a rare, monogenic disease characterized by excessive insulin secretion. We aimed to evaluate all probands with suspected CHI in Norway registered over the past 2 decades.

Methods

The study included 98 probands. Clinical data were cumulated from medical records. All probands were screened for variants in the genes ABCC8 and KCNJ11. Other CHI-related genes were Sanger-sequenced as indicated by the patients’ phenotype (n = 75) or analyzed by next-generation sequencing employing a panel of 30 CHI-related genes (n = 23).

Results

Twenty-one probands (21%) received a diagnosis other than CHI, the most common being idiopathic ketotic hypoglycemia (9%) or syndromic hyperinsulinism (4%). In the final cohort of 77 CHI probands, genetic findings were revealed in 46 (60%). ABCC8 variants were most common (n= 40), and 5 novel variants were identified. One proband harbored both the pathogenic GCK variant p.(Ala456Val) and the ABCC8 variant p.(Gly505Cys). Although most ABCC8 variants caused immediate disease onset with severe hypoglycemia and were diazoxide-unresponsive, 8 probands had a heterozygous, apparently dominant variant with milder phenotype. Two probands had pathogenic variants in GLUD1, whereas variants in HADH, HNF4A, KCNJ11, and HK1 were identified in 1 proband each, the latter being noncoding. Neurologic sequelae were reported in 53% of the CHI probands. Of nonsurgically treated probands, 43% had spontaneous resolution. The minimum birth prevalence of CHI in Norway is 1:19,400 live births. Main Conclusion Individuals with disease-causing ABCC8 variants dominated our cohort. Patients with known genetic etiology had earlier and more severe disease onset than genetically unsolved patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital HyperinsulinismSulfonylurea ReceptorsHumansFemaleMaleNorwayPotassium Channels, Inwardly RectifyingInfantCohort StudiesInfant, NewbornChild, PreschoolPhenotypeMutationChildKcnj11 Channel

Stichwörter der Autor:innen

genetic testinghyperinsulinemic hypoglycemiainsulin dysregulationmonogenic diseaseneurologic sequelapersistent hypoglycemia

Substanzen

Sulfonylurea ReceptorsPotassium Channels, Inwardly RectifyingKcnj11 ChannelABCC8 protein, human

Autor:innen und Institutionen

  • Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway.
  • Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, N-5020 Bergen, Norway.
  • Department of Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway.
  • Children and Youth Clinic, Haukeland University Hospital, N-5021 Bergen, Norway.
  • Department of Pathology and Section for Cancer Genomics, Haukeland University Hospital, N-5021 Bergen, Norway.

ORCID-Profile: Christoffer Drabløs Velde, Pål Rasmus Njølstad, Anders Molven

Förderung

  • University of Bergen
  • Western Norway Regional Health Authority
  • Research Council of Norway
  • Novo Nordisk Foundation
  • European Research Council
  • Stiftelsen Trond Mohn Foundation
  • Mohn Center of Diabetes Precision Medicine

Zitieren

APA

Velde, C. D., Molnes, J., Berland, S., Njølstad, P. R., & Molven, A. (2025). Clinical and Genetic Characteristics of Congenital Hyperinsulinism in Norway: A Nationwide Cohort Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae459

Vancouver

Velde CD, Molnes J, Berland S, Njølstad PR, Molven A. Clinical and Genetic Characteristics of Congenital Hyperinsulinism in Norway: A Nationwide Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae459

BibTeX
@article{Velde2025,
  author = {Velde, Christoffer Drabløs and Molnes, Janne and Berland, Siren and Njølstad, Pål Rasmus and Molven, Anders},
  title = {Clinical and Genetic Characteristics of Congenital Hyperinsulinism in Norway: A Nationwide Cohort Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae459}
}
Kostenlos starten →